{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T01:11:29Z","timestamp":1795137089756,"version":"4.10.3"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP20dm0107119"],"award-info":[{"award-number":["JP20dm0107119"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31701009"],"award-info":[{"award-number":["31701009"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004543","name":"China Scholarship Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004543","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Neuropsychopharmacology"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.euroneuro.2021.04.010","type":"journal-article","created":{"date-parts":[[2021,5,7]],"date-time":"2021-05-07T13:30:08Z","timestamp":1620394208000},"page":"55-63","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["Intranasal administration of transforming growth factor-\u03b21 elicits rapid-acting antidepressant-like effects in a chronic social defeat stress model: A role of TrkB signaling"],"prefix":"10.1016","volume":"50","author":[{"given":"Yan","family":"Wei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijia","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euroneuro.2021.04.010_bib0001","first-page":"148","article-title":"The neurobiology of depression, ketamine and rapid-acting antidepressants: is it glutamate inhibition or activation?","volume":"190","author":"Abdallah","year":"2018","journal-title":"Pharmacol. Ther."},{"issue":"7354","key":"10.1016\/j.euroneuro.2021.04.010_bib0002","first-page":"91","article-title":"NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses","volume":"475","author":"Autry","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.euroneuro.2021.04.010_bib0003","first-page":"11252","article-title":"A key role for TGF-beta1 in hippocampal synaptic plasticity and memory","volume":"5","author":"Caraci","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.euroneuro.2021.04.010_bib0004","first-page":"374","article-title":"Neurobiological links between depression and AD: the role of TGF-beta1 signaling as a new pharmacological target","volume":"130","author":"Caraci","year":"2018","journal-title":"Pharmacol. Res."},{"issue":"5","key":"10.1016\/j.euroneuro.2021.04.010_bib0005","first-page":"1846","article-title":"Identification of a low-molecular weight TrkB antagonist with anxiolytic and antidepressant activity in mice","volume":"121","author":"Cazorla","year":"2011","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.euroneuro.2021.04.010_bib0006","first-page":"53","article-title":"Comparison of antidepressant and side effects in mice after intranasal administration of (R,S)-ketamine, (R)-ketamine, and (S)-ketamine","volume":"181","author":"Chang","year":"2019","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"2","key":"10.1016\/j.euroneuro.2021.04.010_bib0007","first-page":"271","article-title":"Lack of dopamine D1 receptors in the antidepressant actions of (R)-ketamine in a chronic social defeat stress model","volume":"270","author":"Chang","year":"2020","journal-title":"Eur. Arch. Psych. Clin. Neurosci."},{"issue":"2","key":"10.1016\/j.euroneuro.2021.04.010_bib0008","article-title":"Protection of TGF-\u03b21 against neuroinflammation and neurodegeneration in A\u03b21-42-induced Alzheimer's disease model rats","volume":"10","author":"Chen","year":"2015","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.euroneuro.2021.04.010_bib0009","article-title":"The neurotrophic receptor Ntrk2 directs lymphoid tissue neovascularization during Leishmania donovani infection","volume":"11","author":"Dalton","year":"2015","journal-title":"PLoS Pathog."},{"issue":"7","key":"10.1016\/j.euroneuro.2021.04.010_bib0010","first-page":"4653","article-title":"Astrocytes and the TGF-\u03b21 pathway in the healthy and diseased brain: a double-edged sword","volume":"56","author":"Diniz","year":"2019","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.euroneuro.2021.04.010_bib0011","first-page":"155","article-title":"Evaluation of intranasal delivery route of drug administration for brain targeting","volume":"143","author":"Erdo","year":"2018","journal-title":"Brain Res. Bull."},{"issue":"7","key":"10.1016\/j.euroneuro.2021.04.010_bib0012","first-page":"1592","article-title":"Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD)","volume":"25","author":"Fava","year":"2020","journal-title":"Mol. Psychiatry"},{"issue":"1","key":"10.1016\/j.euroneuro.2021.04.010_bib0013","first-page":"9","article-title":"Antidepressant potential of (R)-ketamine in rodent models: comparison with (S)-Ketamine","volume":"361","author":"Fukumoto","year":"2017","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"8","key":"10.1016\/j.euroneuro.2021.04.010_bib0014","first-page":"1183","article-title":"A standardized protocol for repeated social defeat stress in mice","volume":"6","author":"Golden","year":"2011","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.euroneuro.2021.04.010_bib0015","first-page":"857","article-title":"Antidepressant drugs and physical activity: a possible synergism in the treatment of major depression?","volume":"11","author":"Guerrera","year":"2020","journal-title":"Front. Psychol."},{"issue":"74","key":"10.1016\/j.euroneuro.2021.04.010_bib0016","first-page":"4440","article-title":"Intranasal administration of CNS therapeutics to awake mice","author":"Hanson","year":"2013","journal-title":"J. Vis. Exp."},{"issue":"10","key":"10.1016\/j.euroneuro.2021.04.010_bib0017","first-page":"613","article-title":"Rapid-acting antidepressant ketamine, its metabolites and other candidates: a historical overview and future perspective","volume":"73","author":"Hashimoto","year":"2019","journal-title":"Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.euroneuro.2021.04.010_bib0018","article-title":"Molecular mechanisms of the rapid-acting and long-lasting antidepressant actions of (R)-ketamine","volume":"177","author":"Hashimoto","year":"2020","journal-title":"Biochem. Pharmacol."},{"issue":"1","key":"10.1016\/j.euroneuro.2021.04.010_bib0019","first-page":"106","article-title":"The role of TGF-beta superfamily signaling in neurological disorders","volume":"50","author":"Kashima","year":"2018","journal-title":"Acta Biochim. Biophys. Sin."},{"issue":"7","key":"10.1016\/j.euroneuro.2021.04.010_bib0020","first-page":"1459","article-title":"Single-dose infusion ketamine and non-ketamine N-methyl-D-aspartate receptor antagonists for unipolar and bipolar depression: a meta-analysis of efficacy, safety and time trajectories","volume":"46","author":"Kishimoto","year":"2016","journal-title":"Psychol. Med."},{"issue":"5","key":"10.1016\/j.euroneuro.2021.04.010_bib0021","first-page":"774","article-title":"Ketamine: a paradigm shift for depression research and treatment","volume":"101","author":"Krystal","year":"2019","journal-title":"Neuron"},{"issue":"8","key":"10.1016\/j.euroneuro.2021.04.010_bib0022","first-page":"1298","article-title":"The role of IL-12 and TGF-beta1 in the pathophysiology of major depressive disorder","volume":"6","author":"Lee","year":"2006","journal-title":"Int. Immunopharmacol."},{"issue":"3","key":"10.1016\/j.euroneuro.2021.04.010_bib0023","first-page":"405","article-title":"Regulation of glutamate transporter 1 via BDNF-TrkB signaling plays a role in the anti-apoptotic and antidepressant effects of ketamine in chronic unpredictable stress model of depression","volume":"233","author":"Liu","year":"2016","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.euroneuro.2021.04.010_bib0024","first-page":"117","article-title":"Intranasal delivery of transforming growth factor-beta1 in mice after stroke reduces infarct volume and increases neurogenesis in the subventricular zone","volume":"9","author":"Ma","year":"2008","journal-title":"BMC Neurosci."},{"issue":"4","key":"10.1016\/j.euroneuro.2021.04.010_bib0025","first-page":"271","article-title":"Intranasally delivered TGF-beta1 enters brain and regulates gene expressions of its receptors in rats","volume":"74","author":"Ma","year":"2007","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.euroneuro.2021.04.010_bib0026","first-page":"139","article-title":"Antidepressant actions of ketamine: from molecular mechanisms to clinical practice","volume":"30","author":"Monteggia","year":"2015","journal-title":"Curr. Opin. Neurobiol."},{"issue":"7","key":"10.1016\/j.euroneuro.2021.04.010_bib0027","first-page":"472","article-title":"Targeting glutamate signalling in depression: progress and prospects","volume":"16","author":"Murrough","year":"2017","journal-title":"Nat. Rev. Drug Discov."},{"issue":"10","key":"10.1016\/j.euroneuro.2021.04.010_bib0028","first-page":"1134","article-title":"Antidepressant efficacy of ketamine in treatment-resistant major depression: a two-site randomized controlled trial","volume":"170","author":"Murrough","year":"2013","journal-title":"Am. J. Psychiatry"},{"issue":"1\u20133","key":"10.1016\/j.euroneuro.2021.04.010_bib0029","first-page":"217","article-title":"Elevated macrophage migration inhibitory factor and decreased transforming growth factor-beta levels in major depression \u2013 no influence of celecoxib treatment","volume":"134","author":"Musil","year":"2011","journal-title":"J. Affect. Disord."},{"issue":"10","key":"10.1016\/j.euroneuro.2021.04.010_bib0030","first-page":"950","article-title":"Ketamine and other NMDA antagonists: early clinical trials and possible mechanisms in depression","volume":"172","author":"Newport","year":"2015","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2021.04.010_bib0031","first-page":"e666","article-title":"BDNF-TrkB signaling in the nucleus accumbens shell of mice has key role in methamphetamine withdrawal symptoms","volume":"5","author":"Ren","year":"2015","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.euroneuro.2021.04.010_bib0032","first-page":"60","article-title":"Alteration of immune markers in a group of melancholic depressed patients and their response to electroconvulsive therapy","volume":"205","author":"Rush","year":"2016","journal-title":"J. Affect. Disord."},{"issue":"12","key":"10.1016\/j.euroneuro.2021.04.010_bib0033","first-page":"2449","article-title":"Alterations in brain-derived neurotrophic factor (BDNF) and its precursor proBDNF in the brain regions of a learned helplessness rat model and the antidepressant effects of a TrkB agonist and antagonist","volume":"25","author":"Shirayama","year":"2015","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"3","key":"10.1016\/j.euroneuro.2021.04.010_bib0034","first-page":"369","article-title":"Transforming growth factor-beta1 enhances expression of brain-derived neurotrophic factor and its receptor, TrkB, in neurons cultured from rat cerebral cortex","volume":"66","author":"Sometani","year":"2001","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.euroneuro.2021.04.010_bib0035","first-page":"e741","article-title":"Role of hippocampal p11 in the sustained antidepressant effect of ketamine in the chronic unpredictable mild stress model","volume":"6","author":"Sun","year":"2016","journal-title":"Transl. Psychiatry"},{"issue":"1\u20132","key":"10.1016\/j.euroneuro.2021.04.010_bib0037","first-page":"121","article-title":"Transforming growth factor\u2013\u03b2 signaling in brain disorders","volume":"17","author":"Vivien","year":"2006","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.euroneuro.2021.04.010_bib0036","article-title":"A historical review of antidepressant effects of ketamine and its enantiomers","volume":"190","author":"Wei","year":"2020","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.euroneuro.2021.04.010_bib0038","unstructured":"Wei, Y., Chang, L., Hashimoto, K., 2021. Molecular mechanisms underlying the antidepressant actions of arketamine: beyond the NMDA receptor. Mol. Psychiatry in press. doi:10.1038\/s41380-021-01121-1."},{"issue":"1","key":"10.1016\/j.euroneuro.2021.04.010_bib0039","first-page":"18","article-title":"Mechanistic target of rapamycin-independent antidepressant effects of (R)-ketamine in a social defeat stress model","volume":"83","author":"Yang","year":"2018","journal-title":"Biol. Psychiatry"},{"issue":"7","key":"10.1016\/j.euroneuro.2021.04.010_bib0040","first-page":"pyu121","article-title":"Regional differences in brain-derived neurotrophic factor levels and dendritic spine density confer resilience to inescapable stress","volume":"18","author":"Yang","year":"2015","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.euroneuro.2021.04.010_bib0041","first-page":"e632","article-title":"R-ketamine: a rapid-onset and sustained antidepressant without psychotomimetic side effects","volume":"5","author":"Yang","year":"2015","journal-title":"Transl. Psychiatry"},{"issue":"1","key":"10.1016\/j.euroneuro.2021.04.010_bib0042","first-page":"280","article-title":"Molecular and cellular mechanisms underlying the antidepressant effects of ketamine enantiomers and its metabolites","volume":"9","author":"Yang","year":"2019","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.euroneuro.2021.04.010_bib0043","first-page":"30659","article-title":"Role of Keap1-Nrf2 signaling in depression and dietary intake of glucoraphanin confers stress resilience in mice","volume":"6","author":"Yao","year":"2016","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.euroneuro.2021.04.010_bib0044","first-page":"135","article-title":"Pro- and anti-inflammatory cytokines expression in rat's brain and spleen exposed to chronic mild stress: involvement in depression","volume":"225","author":"You","year":"2011","journal-title":"Behav. Brain Res."},{"issue":"7604","key":"10.1016\/j.euroneuro.2021.04.010_bib0045","first-page":"481","article-title":"NMDAR inhibition-independent antidepressant actions of ketamine metabolites","volume":"533","author":"Zanos","year":"2016","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.euroneuro.2021.04.010_bib0046","first-page":"621","article-title":"Ketamine and ketamine metabolite pharmacology: insights into therapeutic mechanisms","volume":"70","author":"Zanos","year":"2018","journal-title":"Pharmacol. Rev."},{"issue":"8","key":"10.1016\/j.euroneuro.2021.04.010_bib0047","first-page":"856","article-title":"A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression","volume":"63","author":"Zarate","year":"2006","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.euroneuro.2021.04.010_bib0048","first-page":"110","article-title":"Abnormal expression of colony stimulating factor 1 receptor (CSF1R) and transcription factor PU.1 (SPI1) in the spleen from patients with major psychiatric disorders: a role of brain-spleen axis","volume":"272","author":"Zhang","year":"2020","journal-title":"J. Affect. Disord."},{"issue":"1","key":"10.1016\/j.euroneuro.2021.04.010_bib0049","first-page":"186","article-title":"A key role of the subdiaphragmatic vagus nerve in the depression-like phenotype and abnormal composition of gut microbiota in mice after lipopolysaccharide administration","volume":"10","author":"Zhang","year":"2020","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.euroneuro.2021.04.010_bib0050","first-page":"137","article-title":"R (-)-ketamine shows greater potency and longer lasting antidepressant effects than S (+)-ketamine","volume":"116","author":"Zhang","year":"2014","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"4","key":"10.1016\/j.euroneuro.2021.04.010_bib0051","first-page":"pyu077","article-title":"Antidepressant effects of TrkB ligands on depression-like behavior and dendritic changes in mice after inflammation","volume":"18","author":"Zhang","year":"2014","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"23","key":"10.1016\/j.euroneuro.2021.04.010_bib0052","first-page":"4325","article-title":"Comparison of ketamine, 7,8-dihydroxyflavone, and ANA-12 antidepressant effects in the social defeat stress model of depression","volume":"232","author":"Zhang","year":"2015","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.euroneuro.2021.04.010_bib0053","first-page":"134","article-title":"Prophylactic effects of sulforaphane on depression-like behavior and dendritic changes in mice after inflammation","volume":"39","author":"Zhang","year":"2017","journal-title":"J. Nutr. Biochem."},{"issue":"1","key":"10.1016\/j.euroneuro.2021.04.010_bib0054","first-page":"83","article-title":"An update on ketamine and its two enantiomers as rapid-acting antidepressants","volume":"19","author":"Zhang","year":"2019","journal-title":"Exp. Rev. Neurother."},{"issue":"3","key":"10.1016\/j.euroneuro.2021.04.010_bib0055","first-page":"447","article-title":"Splenic NKG2D confers resilience versus susceptibility in mice after chronic social defeat stress: beneficial effects of (R)-ketamine","volume":"271","author":"Zhang","year":"2021","journal-title":"Eur. Arch. Psych. Clin. Neurosci."},{"issue":"1","key":"10.1016\/j.euroneuro.2021.04.010_bib0056","first-page":"32","article-title":"Essential role of microglial transforming growth factor-\u03b21 in antidepressant actions of (R)-ketamine and the novel antidepressant TGF-\u03b21","volume":"10","author":"Zhang","year":"2020","journal-title":"Transl. Psychiatry"}],"container-title":["European Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X21002078?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X21002078?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T18:00:08Z","timestamp":1760378408000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924977X21002078"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":56,"alternative-id":["S0924977X21002078"],"URL":"https:\/\/doi.org\/10.1016\/j.euroneuro.2021.04.010","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.740092015.793588216","asserted-by":"object"}]},"ISSN":["0924-977X"],"issn-type":[{"value":"0924-977X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intranasal administration of transforming growth factor-\u03b21 elicits rapid-acting antidepressant-like effects in a chronic social defeat stress model: A role of TrkB signaling","name":"articletitle","label":"Article Title"},{"value":"European Neuropsychopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euroneuro.2021.04.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. and ECNP. All rights reserved.","name":"copyright","label":"Copyright"}]}}